Oscar Health, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 18, 2025: 7.39

Oscar Health, Inc. Enterprise Value to EBITDA (EV/EBITDA) is 7.39 on July 18, 2025, a -50.44% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Oscar Health, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 41.32 on July 18, 2025, which is 458.85% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Oscar Health, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 3.97 on July 18, 2025, which is -46.32% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Oscar Health, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 17.73.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization